Fundraising Fox

Novalis LifeSciencesFull Portfolio

17 tracked investments · listed companies and verified rows first

Quanterixquanterix.comin𝕏NASDAQ: QTRXJun 2017SEC filingmedium confidence

Quanterix develops technology for highly sensitive detection of protein biomarkers using non-invasive sample types, aimed at early disease detection and prevention.

BiotechDigital HealthHealthtechMedical DevicesLexington, US

John Connolly(Director)Douglas Cole(Director)David Walt(Director)Martin Madaus(Director)Dennis Sandstedt(Director)Ernest Orticerio(Executive Officer)

Board seatMarijn DekkersPaul Meister· per SEC Form D · $6.5M raise · filed Jul 2019

Activ Surgicalactivsurgical.comin𝕏Jul 2020SEC filingmedium confidence

Activ Surgical develops digital surgery imaging technology that uses augmented reality, artificial intelligence, and machine learning to help surgeons visualize critical physiological structures during surgery.

AI & Machine LearningHealthtechMedical DevicesBoston, US

Michael Ruehlman(Executive Officer)Emily Casey(Director)David Wells(Director)Peter Kim(Director)Todd Usen(Executive Officer, Director)

BoardAshok Krishnamurthi(Director)

Board seatPaul Meister· per SEC Form D · $15M raise · filed Jul 2020

Agbiomeagbiome.comNov 2019SEC filingmedium confidence

AgTechResearch Triangle Park, US

Scott Uknes(Manager)Larry Robbins(Secretary)Thomas Dietz(Manager)John Ryals(Manager)Paul Schulze-Lefert(President)Michael Koziel(Vice President and Manager)

Board seatMarijn Dekkers· per SEC Form D · $117.2M raise · filed Feb 2022

Animolanimol-discovery.comJul 2022

Animol Discovery develops small-molecule pharmaceuticals for companion and farm animals, targeting unmet veterinary needs.

AgTechAI & Machine LearningBiotechBoston, US

Philip Austin(Executive Officer, Director)Andrew Plant(Executive Officer, Director)

BoardMichelle Haven(Director)

Board seatMarijn Dekkers· per SEC Form D

Enko ChemJun 2020SEC filingmedium confidence

BiotechBoston, US

Philip Austin(Director)Steffen Helmling(Director)Jacqueline Heard(Executive Officer, Director)

Board seatMarijn Dekkers· per SEC Form D · $80M raise · filed Dec 2022

Flywheel Exchange, Inc.flywheel.ioinDec 2025

Flywheel provides a platform for organizing, managing, and sharing medical imaging data.

AI & Machine LearningData & InfrastructureHealthtechMedical DevicesMinneapolis, US

Brian Wandell(Co-founder)Gunnar Schaefer(Co-founder)Colby Moosman(Executive Officer)Matthew D. Michela(Executive Officer, Director)Sarah Fazio(Executive Officer)Danny J. Cunagin(Director)

Board seatMarijn DekkersPaul MeisterDevin Leake· per SEC Form D

Vizgenvizgen.comin𝕏Mar 2021SEC filingmedium confidence

Vizgen develops spatial profiling instruments and reagents for high-throughput analysis of gene expression and protein distribution in tissue samples.

AI & Machine LearningBiotechDeep TechMedical DevicesCambridge, US

George Emanuel(Scientific Cofounder, VP & Portfolio Owner, Instruments)Jiang He(Scientific Cofounder, VP & Portfolio Owner, Reagents & Scientific Affairs)Robert Carson(Executive Officer, Director)Terry Lo(Director)Seth Benson(Executive Officer)Simona Levi(Executive Officer)

Board seatMarijn Dekkers· per SEC Form D · $37M raise · filed Apr 2021

Bluewhalebluewhale.bioinOct 2025

Synecta develops cell-derived nanoparticles that activate immune cells for cell therapy manufacturing, improving potency and reducing costs.

BiotechDeep TechMedical DevicesPhiladelphia, US

Peter Keller(Executive Officer, Director)

BoardPaul Meister(Director)Elaine Heron(Director)Paula Cannon(Director)Beate Mueller-Tiemann(Director)

Enko Websiteenko.agin𝕏

Enko discovers and develops novel crop protection products for farmers using a proprietary AI and machine learning discovery platform to combat pests and diseases.

AgTechAI & Machine LearningBiotech

Tom Meade(Chief Science Officer)

LevitasBiolevitasbio.comin𝕏
Mercy BioAnalyticsmercybio.com
Ori Biotechoribiotech.comin𝕏
Orogentxorogentx.com

Orogen Therapeutics is a drug discovery company that uses AI-enabled DNA-encoded library (DEL) technology and machine learning to identify novel small-molecule compounds targeting cytokine-related immuno-inflammatory disorders.

AI & Machine LearningBiotechDeep Tech

Mark Pykett(CEO)

Skylinedxskylinedx.comin𝕏

SkylineDx develops molecular diagnostic tests based on gene expression analysis to assess disease risk and predict treatment response in oncology and hematology.

AI & Machine LearningHealthtechMedical Devices

Telesis Biotelesisbio.cominJun 2023

Telesis Bio develops automated platforms for RNA and DNA synthesis to accelerate therapeutic discovery workflows in drug development, cell and gene therapy, and vaccine development.

AI & Machine LearningBiotechDeep TechHealthtechSan Diego, US

Franklin R. Witney(Chair of the Board of Directors)Eric Esser(Executive Officer)William F. Snider(Director)Andrea L. Jackson(Director)Christine A. Tsingos(Director)Robert H. Cutler(Executive Officer)

Vigilant Biosciencesvigilantbiosciences.comin

BiotechDigital HealthMedical DevicesMiami, US

Matthew H. J. Kim(Executive Officer, Director)Timothy Barabe(Director)Eric Stone(Director)

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.